China Renaissance Capital Investment
Overview
China Renaissance Capital Investment is a leading Chinese middle market private equity firm with a pedigree gained over 17 years of growth capital and control investing . The firm focuses on funding business transformation and is an impact investor . It specializes in spotting opportunities in applying know-how to emerging market demand and uses its experience of international markets to acquire businesses that can help upgrade domestic Chinese companies . The firm's investment focuses are decarbonization technologies and the SMART (Smart Manufacturing, Automation, Robot and Technology) sector .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| MediTrust Health | Aug 2021 | Series C | - |
| Tujia | Jun 2014 | Series C | Co-investor |
| Annoroad Gene Technology | Dec 2013 | Series A | Co-investor |
| Nanjing Solidot Electronic Technology Co., Ltd. | Sep 2022 | Series A | Co-investor |
| Chiral Quest (Suzhou) Co., Ltd. | Nov 2008 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is China Renaissance Capital Investment based?
China Renaissance Capital Investment is headquartered in Hong Kong SAR.
When was China Renaissance Capital Investment founded?
China Renaissance Capital Investment was founded in 2005.
How many portfolio companies does China Renaissance Capital Investment have?
China Renaissance Capital Investment has 7 portfolio companies in Caplight's dataset.
What are some companies in China Renaissance Capital Investment's portfolio?
Portfolio companies visible on Caplight include MediTrust Health, Tujia, Annoroad Gene Technology, Nanjing Solidot Electronic Technology Co., Ltd., Chiral Quest (Suzhou) Co., Ltd..
What was China Renaissance Capital Investment's most recent investment shown here?
China Renaissance Capital Investment's most recent investment in this portfolio sample was in Nanjing Solidot Electronic Technology Co., Ltd. in 2022.
What sectors does China Renaissance Capital Investment focus on?
China Renaissance Capital Investment focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Consumer & Commerce, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Energy & Sustainability, Mobility, Transportation & Logistics, FinTech, Telecommunications & Networking, Real Estate & PropTech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Telecommunications & Networking.
What company stages does China Renaissance Capital Investment focus on?
China Renaissance Capital Investment typically invests at the Mid stage.
What is China Renaissance Capital Investment's AUM?
China Renaissance Capital Investment's assets under management are estimated between $1.0B and $10.0B.